CLIN DRUG INVEST 润色咨询

CLINICAL DRUG INVESTIGATION

出版年份:1995 年文章数:870 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=b0751533, cover=https://img.medsci.cn/images/journal/cover/2021/LFq_202109271314428830.jpg, fullname=CLINICAL DRUG INVESTIGATION, abbr=CLIN DRUG INVEST, pyear=1995, frequence=Monthly, articleNumbers=870, citedSelf2015=3.2, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1173-2563, greenSci=https://www.greensci.net/search?kw=1173-2563, scijournal=https://www.scijournal.org/impact-factor-of-CLIN-DRUG-INVEST.shtml, medsciHotlightString=null, medsciHotlightRealtime=3.319, medsciHotlight=2.981, medsciHotlight5year=4.44571, citescore=4.3, hIndex=58, impactFactor=3.2, orgnization=Adis International Ltd, orgnizationUrl=http://www.adisonline.info/, country=United Kingdom, countryCn=英国, isOa=0, isOaString=否, sciScie=Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 4区, smallclassCas=医学 4 区, website=https://link.springer.com/journal/40261, websiteHits=8746, guideForAuthor=null, guideForAuthorHits=12, submitWebsite=https://www.editorialmanager.com/cdia/, submitWebsiteHits=2560, content=Published by Adis International Limited (now part of Wolters Kluwer Health). ISSN: 1173-2563.<br /><br />Clinical Drug Investigation gives you rapid access to the best designed, peer reviewed clinical and pharmacoeconomic studies worldwide, allowing you to keep up to date with the latest original research in this exciting area. The Journal's aim is rapid publication of original research covering all phases of clinical drug development and therapeutic use of drugs. This includes clinical trials, outcomes research, clinical pharmacoeconomic studies, pharmacoepidemiology studies with a strong link to optimum prescribing practice for a drug or group of drugs, clinical pharmacodynamic and clinical pharmacokinetic studies with a strong link to clinical practice and, in some instances, pharmacodynamic or pharmacokinetic studies in healthy volunteers, but in which some established or purported implications for clinical prescribing are discussed. In addition, short communications and case study reports that meet these criteria are also encouraged, as are letters to the editor., totalCites=2785, brief=CLIN DRUG INVEST杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=药学" >药学</a></strong>”子行业的偏低级别杂志, articleType=论著为主,其它类型文章约占5-10%, medsciHeat=<span style="color: #000000;">黑</span>, medsciComment=杂志水平一般,也很冷门,关注人少,审稿周期可能也不一定快,如果文章质量不佳,或时间不紧的话,可以考虑考虑。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=b0751533'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=51579, tagName=单抗靶向药物, createdHits=1), ImpactFactorTagDto(id=598, tagName=新药, createdHits=1), ImpactFactorTagDto(id=109, tagName=临床试验, createdHits=1), ImpactFactorTagDto(id=1080, tagName=麻醉, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=1.7), GetImpactFactorCiteScoreListResponse(year=2017, citescore=1.98), GetImpactFactorCiteScoreListResponse(year=2018, citescore=2.04), GetImpactFactorCiteScoreListResponse(year=2019, citescore=3.9), GetImpactFactorCiteScoreListResponse(year=2020, citescore=4.3)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=4.585), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=3.194), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=2.899), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=2.99), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=3.319)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pharmacology (medical) , rank=100/232)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=PHARMACOLOGY & PHARMACY, rank=Q3)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1173-2563[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=CLINICAL DRUG INVESTIGATION[ta], article_number=115, article_number_cn=10, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
CLIN DRUG INVEST/CLINICAL DRUG INVESTIGATION
ISSN
1173-2563
影响指数话题
预警等级
MedSci期刊指数
3.319 (MedSci实时期刊指数) | 4.44571 (5年期刊指数)
CiteScore值
4.3
h-index
58
h5-median
暂无数据
出版社/管理机构
杂志由 Adis International Ltd 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Monthly
出版年份
1995
是否OA
被收录情况
Science Citation Index|Science Citation Index Expanded|Current Contents - Clinical Medicine|Current Contents - Life Sciences|BIOSIS Previews
JCR分区
PHARMACOLOGY & PHARMACY Q3
中科院分区
大类:医学 4区
小类:医学 4 区